Jeffrey Smith’s Colgate-Palmolive CL Stock Holding History

Jeffrey Smith’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-168,595	Closed	-$12.3M	–	23
2017 Q1	$12.3M	Buy	+168,595	New	+$11.8M	0.38%	17

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jeffrey Smith's CL Position: Q2 2017 in Review

Jeffrey Smith sold out of Colgate-Palmolive (CL) in Q2 2017, closing a stake of 168,595 shares — an estimated $12.3M sold.

Jeffrey Smith first reported a position in CL in Q1 2017 and held it in 1 quarter. The position peaked at $12.3M in Q1 2017. 1,370 funds tracked by Wall St. Rank hold CL as of Q2 2017.

Jeffrey Smith reported no remaining Colgate-Palmolive position as of Q2 2017 after selling out during the quarter.
Jeffrey Smith sold 168,595 Colgate-Palmolive shares in Q2 2017, an estimated $12.3M.
Jeffrey Smith first reported a position in Colgate-Palmolive in Q1 2017 and held it in 1 quarter.
Jeffrey Smith's Colgate-Palmolive position peaked at $12.3M in Q1 2017.
1,370 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2017.

Based on Starboard Value's 13F filing for Q2 2017, filed 11 Aug 2017.